ABBV vs CPHI
AbbVie Inc (ABBV) versus China Pharma Holdings Inc (CPHI) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported CPHI revenue for 2024-12-31 was $4.5M. Net income was -$4.7M. Revenue was down 35.4% from 2023-12-31 to 2024-12-31. CPHI currently screens at market cap $29.0M.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. CPHI currently screens at market cap $29.0M.
Not investment advice. Open the ABBV and CPHI stock pages for the full models.
Not investment advice.